Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Paraganglioma peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Paraganglioma. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
2 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 16 selected PubMed records and 4 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Paraganglioma unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03206060
PeptideScanner retained ClinicalTrials.gov record NCT03206060 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 26, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT04711135
PeptideScanner retained ClinicalTrials.gov record NCT04711135 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 12, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Gallium Ga 68 dotatate · 2026-10-26
ClinicalTrials.gov record NCT03206060
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-02-12
ClinicalTrials.gov record NCT04711135
Active, not recruiting at the retained observation.
Open attributed record →